One of the most commonly reported side effects of microdosing is a reduced desire for alcohol. Here's what the research shows and why it happens.
Addiction: With Mushroom Support vs. Without
| Metric |
Without Mushroom Support |
With Mushroom Support (Lion's Mane + Psilocybin) |
| Sleep Quality |
Severely disrupted; withdrawal and cravings interrupt sleep |
Improved sleep quality; reduced craving-driven nighttime arousal |
| Emotional Range |
Emotional dysregulation; substance used to manage feelings |
Greater emotional processing capacity without substance reliance |
| Energy Levels |
Cycles of stimulation and crash; chronic fatigue in recovery |
More stable energy as neurochemistry normalizes |
| Anxiety / Rumination |
Anxiety drives craving; craving drives use in a vicious cycle |
Reduced craving intensity; psilocybin interrupts the addiction loop |
| Sense of Connection |
Isolation; relationships damaged by addiction |
Increased sense of connection reduces the pull of substance use |
| Cognitive Clarity |
Impaired by substance use and withdrawal fog |
Cognitive recovery supported by Lion's Mane neurogenesis |
| Motivation & Drive |
Motivation hijacked by addiction; only substance matters |
Reconnection with values and long-term goals |
| Time to Noticeable Change |
Addiction is chronic and relapsing without sustained support |
Johns Hopkins smoking study: 80% abstinence at 6 months after 2–3 psilocybin sessions |
Sources: Johns Hopkins Medicine, Imperial College London, NEJM 2021 psilocybin trial, Mori et al. 2009 (Lion's Mane), Stamets 2019 (microdosing survey)
## The Unexpected Side Effect
In Fadiman's observational study, reduced alcohol consumption was one of the most commonly reported unsolicited benefits of microdosing — reported by participants who weren't trying to reduce their drinking.
## The Research on Psilocybin and Alcohol
A 2022 randomized controlled trial at NYU (Bogenschutz et al., *JAMA Psychiatry*) found that two sessions of psilocybin-assisted therapy produced an 83% reduction in heavy drinking days at 8-month follow-up. This is the largest effect size ever recorded for any alcohol use disorder treatment.
> **Happy Shrooomz's recommended protocol** is based on the Fadiman Protocol with modifications from observational data: 0.1–0.3g every third day (Day 1: dose, Day 2: observe, Day 3: rest). This schedule prevents tolerance buildup while allowing neuroplasticity effects to accumulate. [Happy Shrooomz capsules](https://shrooomz.com/store/product/happy-shrooomz) are precision-dosed at 0.15g for exact protocol adherence.
## Why It Works
Alcohol use disorder involves rigid behavioral patterns reinforced by strong neural pathways. Psilocybin's neuroplasticity effect disrupts these patterns — the same mechanism that makes it effective for depression. People describe the experience as "the compulsion just wasn't there anymore" rather than "I was resisting the urge."
## For Microdosers
The effect in microdosing is subtler than in therapeutic sessions, but consistently reported. The most common description: alcohol becomes less appealing, not because of willpower, but because the underlying emotional need it was serving has been addressed.
[See the protocol →](/research-checkout)
*This article is for informational purposes only and does not constitute medical advice.*
Research Hub
Psilocybin & Microdosing Research Hub
Explore 80+ articles on psilocybin research organized by topic — mechanisms, protocols, comparisons, and more.
Browse the Research Hub →